A031801 A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients with Advanced Renal Cell Carcinoma with Bone Metastasis (RadiCal)

Start Date: January 19, 2021

IRB Number: https://www.clinicaltrials.gov/ct2/show/NCT04071223

Condition/Disease: Cancer - Kidney

Principal Investigator: Ding Wang, MD

Purpose of Research: CANCER, RENAL, KIDNEY, KIDNEY CANCER, RENAL CANCER, BONEMETASTASIS, BONE

Status: In Progress

Phone: (313) 916-1784

Filter Results

Consent for Cookie Use